search
Back to results

The Effects of Ventilation Tubes - The SIUTIT Trial (SIUTIT)

Primary Purpose

Otitis Media

Status
Terminated
Phase
Not Applicable
Locations
Greenland
Study Type
Interventional
Intervention
Ventilation tube treatment
Sponsored by
Zealand University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Otitis Media

Eligibility Criteria

9 Months - 36 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion criteria:

  • Children aged 9-36 months.
  • Children with at least one Greenlandic born parent with at least one Greenlandic born parent
  • American Society of Anaesthesiologists physical status classification class 1 and 2
  • B- or C2 - type curve measured by tympanometry at two visits three-four months apart or three episodes of acute otitis media in six months according to medical records or four episodes of acute otitis media in 12 months according to medical records
  • Signed informed consent, signed by the legal guardian Exclusion criteria
  • Children with orofacial cleft, Downs syndrome or known generalised immune deficiency
  • American Society of Anaesthesiologists physical status classification class > 2.
  • Lack of signed informed consent, signed by the legal guardian.

Description of experimental and control intervention Experimental intervention: The intervention group will be treated with bilateral Donaldson ventilation tubes administered in general anaesthesia Control intervention: The control intervention is based on the current practice in Greenland, which includes systemic antibiotic treatment as well as aural toilette and topical antibiotics. Ventilation tube insertion during the study period is not accepted in the control group.

Children in the intervention group as well as the control group will be seen once a year by the visiting ear-nose-and throat (ENT)-specialist and have a final consultation after at least two years after randomisation.

Sites / Locations

  • Aasiaat Regional Hospital
  • Ilulissat Regional Hospital
  • Nuuk Health Center
  • Sisimiut Regional Hospital
  • Tasiilaq Health Center
  • Qaqortoq Regional Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Ventilation tube treatment

Conservative treatment

Arm Description

Ventilation tube insertion in the tympanic membrane

Conventional treatment

Outcomes

Primary Outcome Measures

Number of visits to health clinic
Assessed by investigating medical records.

Secondary Outcome Measures

Number of episodes of acute otitis media
According to medical records
Quality of life
Measured by validated questionnaires OM6 and Caregiver Impact Questionnaire
Number of episodes where per oral or intravenous antibiotics have been administered
According to medical records
Proportion of children with uni- or bilateral tympanic membrane perforations
Based on otoscopical photos, which will be anonymised and evaluated by an ENT-specialist without knowledge of the intervention

Full Information

First Posted
June 3, 2015
Last Updated
November 2, 2020
Sponsor
Zealand University Hospital
Collaborators
Government of Greenland, Agency for Health and Prevention, Copenhagen Trial Unit, Center for Clinical Intervention Research
search

1. Study Identification

Unique Protocol Identification Number
NCT02490332
Brief Title
The Effects of Ventilation Tubes - The SIUTIT Trial
Acronym
SIUTIT
Official Title
The Effects of Ventilation Tubes Versus no Ventilation Tubes for Recurrent Acute Otitis Media or Chronic Otitis Media With Effusion in 9 to 36 Month Old Greenlandic Children - a Randomised Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Terminated
Why Stopped
Failed to include the required number of participants
Study Start Date
February 2016 (undefined)
Primary Completion Date
November 2, 2020 (Actual)
Study Completion Date
November 2, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Zealand University Hospital
Collaborators
Government of Greenland, Agency for Health and Prevention, Copenhagen Trial Unit, Center for Clinical Intervention Research

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The prevalence of otitis media among Greenlandic children is one of the highest in the world and twenty per cent of schoolchildren have impaired hearing in the frequencies for normal speech. Yet, there are no national guidelines to ensure prevention and treatment of recurrent acute otitis media and chronic otitis media with effusion and impaired hearing in Greenlandic children. International studies from the developed part of the world have shown that otitis prone children may benefit from tubulation of the tympanic membrane. However, it is unknown if these results can be applied to Greenlandic children. This PhD project will conduct a randomised controlled trial comparing tubulation of the tympanic membrane, in Greenlandic children aged 9-36 months with recurrent acute otitis media and/or chronic otitis media with effusion, to conservative treatment. The children will be followed for two years. Outcome measures will include number of visits to health clinics, number of tympanic membrane perforations, number of episodes with acute otitis media according to medical records, Quality of life, measured by the validated questionnaires OM6 and Caregiver Impact Questionnaire, number of episodes where per oral or intravenous antibiotics have been administered according to medical records and serious adverse events The trial will be conducted in collaboration with the Greenlandic health authorities and Copenhagen Trial Unit. With this trial the investigators hope to decrease the number of episodes with acute otitis media, the number of Greenlandic children with chronic perforations of the tympanic membrane and hearing impairment and increase quality of life. The results will add important knowledge to the effect of ventilation tube treatment also in an international aspect. There are to date only less than a handful of high quality studies concerning this issue on an international basis. The study will be among the first addressing this problem among populations with high risk of otitis media and is also of interest to other indigenous populations and the developing part of the world.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Otitis Media

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
31 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Ventilation tube treatment
Arm Type
Experimental
Arm Description
Ventilation tube insertion in the tympanic membrane
Arm Title
Conservative treatment
Arm Type
No Intervention
Arm Description
Conventional treatment
Intervention Type
Device
Intervention Name(s)
Ventilation tube treatment
Other Intervention Name(s)
Donaldson myringotomy tube
Intervention Description
Tympanostomy
Primary Outcome Measure Information:
Title
Number of visits to health clinic
Description
Assessed by investigating medical records.
Time Frame
Two years after randomisation
Secondary Outcome Measure Information:
Title
Number of episodes of acute otitis media
Description
According to medical records
Time Frame
Two years after randomisation
Title
Quality of life
Description
Measured by validated questionnaires OM6 and Caregiver Impact Questionnaire
Time Frame
Assessed at baseline, three months after randomisation, one year after randomisation, and at the end of the trial two years after randomisation
Title
Number of episodes where per oral or intravenous antibiotics have been administered
Description
According to medical records
Time Frame
Two years after randomisation
Title
Proportion of children with uni- or bilateral tympanic membrane perforations
Description
Based on otoscopical photos, which will be anonymised and evaluated by an ENT-specialist without knowledge of the intervention
Time Frame
Two years after randomisation
Other Pre-specified Outcome Measures:
Title
Number of episodes of aural discharge
Description
According to medical records
Time Frame
Two years after randomisation
Title
Serious adverse events
Description
Any adverse event that results in death, is life-threatening, requires hospitalisation or prolongation of existing hospitalisation, or results in persistent or significant disability or incapacity.
Time Frame
During the trial

10. Eligibility

Sex
All
Minimum Age & Unit of Time
9 Months
Maximum Age & Unit of Time
36 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria: Children aged 9-36 months. Children with at least one Greenlandic born parent with at least one Greenlandic born parent American Society of Anaesthesiologists physical status classification class 1 and 2 B- or C2 - type curve measured by tympanometry at two visits three-four months apart or three episodes of acute otitis media in six months according to medical records or four episodes of acute otitis media in 12 months according to medical records Signed informed consent, signed by the legal guardian Exclusion criteria Children with orofacial cleft, Downs syndrome or known generalised immune deficiency American Society of Anaesthesiologists physical status classification class > 2. Lack of signed informed consent, signed by the legal guardian. Description of experimental and control intervention Experimental intervention: The intervention group will be treated with bilateral Donaldson ventilation tubes administered in general anaesthesia Control intervention: The control intervention is based on the current practice in Greenland, which includes systemic antibiotic treatment as well as aural toilette and topical antibiotics. Ventilation tube insertion during the study period is not accepted in the control group. Children in the intervention group as well as the control group will be seen once a year by the visiting ear-nose-and throat (ENT)-specialist and have a final consultation after at least two years after randomisation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Malene N Demant, MD
Organizational Affiliation
Køge University Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Preben Homoe, MD, PhD
Organizational Affiliation
Køge University Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Aasiaat Regional Hospital
City
Aasiaat
State/Province
Danmark
ZIP/Postal Code
3950
Country
Greenland
Facility Name
Ilulissat Regional Hospital
City
Ilulissat
State/Province
Danmark
ZIP/Postal Code
3952
Country
Greenland
Facility Name
Nuuk Health Center
City
Nuuk
State/Province
Danmark
ZIP/Postal Code
3900
Country
Greenland
Facility Name
Sisimiut Regional Hospital
City
Sisimiut
State/Province
Danmark
ZIP/Postal Code
3912
Country
Greenland
Facility Name
Tasiilaq Health Center
City
Tasiilaq
State/Province
Danmark
ZIP/Postal Code
3913
Country
Greenland
Facility Name
Qaqortoq Regional Hospital
City
Qaqortoq
ZIP/Postal Code
3920
Country
Greenland

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The final dataset will be publically available in depersonalised format after the end of trial on the Danish Data Archive and ZENODO.
Citations:
PubMed Identifier
28103950
Citation
Demant MN, Jensen RG, Jakobsen JC, Gluud C, Homoe P. The effects of ventilation tubes versus no ventilation tubes for recurrent acute otitis media or chronic otitis media with effusion in 9 to 36 month old Greenlandic children, the SIUTIT trial: study protocol for a randomized controlled trial. Trials. 2017 Jan 19;18(1):30. doi: 10.1186/s13063-016-1770-x.
Results Reference
derived

Learn more about this trial

The Effects of Ventilation Tubes - The SIUTIT Trial

We'll reach out to this number within 24 hrs